Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in United States (VI-1121, Placebo)

Completed
  • Alzheimer's Disease
  • San Francisco, California
  • +10 more
Nov 15, 2013

Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)

Completed
  • Alzheimer's Disease
  • Bapineuzumab 0.5 mg/kg
  • +2 more
  • Birmingham, Alabama
  • +250 more
Oct 30, 2013

Alzheimer's Disease Trial in United States (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)

Completed
  • Alzheimer's Disease
  • Bapineuzumab 0.5 mg/kg
  • +2 more
  • Birmingham, Alabama
  • +185 more
Oct 30, 2013

Alzheimer's Disease Trial in United States (Bapineuzumab (AAB-001))

Terminated
  • Alzheimer's Disease
  • Bapineuzumab (AAB-001)
  • Peoria, Arizona
  • +28 more
Oct 30, 2013

Alzheimer's Disease Trial in Canada, United States (T-817MA, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +34 more
Oct 9, 2013

Alzheimer's Disease Trial in United States (Donepezil, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • San Francisco, California
  • +7 more
Jul 3, 2013

Alzheimer's Disease Trial in United States (TC-5619, Placebo)

Completed
  • Alzheimer's Disease
  • Long Beach, California
  • +9 more
Sep 3, 2013

Alzheimer's Disease Trial in Puerto Rico, United States (Rivastigmine 4.6 mg/24 h (5 cm^2), Rivastigmine 9.5 mg/24 h (10 cm^2),

Completed
Has Results
  • Alzheimer's Disease
  • Rivastigmine 4.6 mg/24 h (5 cm^2)
  • +3 more
  • Tempe, Arizona
  • +94 more
Aug 19, 2013

Alzheimer's Disease Trial in San Francisco (Computer-based Cognitive Training)

Completed
  • Alzheimer's Disease
  • Computer-based Cognitive Training
  • San Francisco, California
    University of California, San Francisco
May 13, 2013

Alzheimer's Disease Trial in Worldwide (LY2062430, Placebo)

Completed
  • Alzheimer's Disease
  • Tucson, Arizona
  • +94 more
Dec 11, 2012

Alzheimer's Disease Trial in Canada, United States (ONO-2506PO)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +86 more
Jun 12, 2012

Alzheimer's Disease Trial in Canada, United States (FK962)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +83 more
Jun 6, 2012

Alzheimer's Disease Trial in United States (florbetapir F 18)

Completed
Has Results
  • Alzheimer's Disease
  • florbetapir F 18
  • Phoenix, Arizona
  • +24 more
May 17, 2012

Alzheimer's Disease Trial in United States (bapineuzumab, )

Completed
  • Alzheimer's Disease
  • Sun City, Arizona
  • +25 more
Mar 12, 2012

Alzheimer's Disease Trial in United States (memantine HCl)

Completed
  • Alzheimer's Disease
  • memantine HCl
  • San Francisco, California
  • +8 more
Mar 1, 2012

Alzheimer's Disease, Dementia Trial in Worldwide (Donepezil HCl)

Completed
  • Alzheimer's Disease
  • Dementia
  • Donepezil hydrochloride
  • Northport, Alabama
  • +41 more
Mar 31, 2011

Alzheimer's Disease Trial in United States (SGS742)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +58 more
Dec 10, 2009

Dementia, Alzheimer's Disease Trial in Worldwide (Rasagiline)

Completed
  • Dementia
  • Alzheimer's Disease
  • Huntsville, Alabama
  • +57 more
Jul 14, 2009

Alzheimer's Disease Trial in Canada, United States (MPC-7869)

Terminated
  • Alzheimer's Disease
  • Alabaster, Alabama
  • +89 more
Aug 1, 2008

Alzheimer's Disease Trial in United States (MEM 1003, Placebo for MEM 1003)

Completed
  • Alzheimer's Disease
  • MEM 1003
  • Placebo for MEM 1003
  • Northport, Alabama
  • +56 more
May 5, 2008

Alzheimer's Disease Trial in United States (PRX-03140)

Completed
  • Alzheimer's Disease
  • Paramount, California
  • +16 more
Jan 29, 2008

Alzheimer's Disease Trial in Canada, United States (VP4896)

Completed
  • Alzheimer's Disease
  • Peoria, Arizona
  • +58 more
Sep 18, 2007

Alzheimer's Disease Trial in San Francisco (Tramiprosate (3APS))

Unknown status
  • Alzheimer's Disease
  • Tramiprosate (3APS)
  • San Francisco, California
    San Francisco Clinical Research Center
Jul 13, 2007